HTA

We support pharmaceutical companies and midsize and large consultancies at different steps of an health technology assessment (HTA) submission.

We support pharmaceutical companies and midsize and large consultancies at different steps of an health technology assessment (HTA) submission. This may include developing a de novo model in Excel, conducting sensitivity analysis, assisting with writing economic sections of the value dossier or preparing references in EndNote™.

We also provide independent review services (see below) for a model developed externally to minimise the risk of errors.